Newsroom

Sorted by: Latest

-

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 05 February 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, a...
-

Xtrackers UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 05 February 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and...
-

Law Offices of Howard G. Smith Encourages Picard Medical, Inc. (PMI) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard investors have until April 3, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PICARD MEDICAL, INC. (PMI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO...
-

Law Offices of Howard G. Smith Encourages Richtech Robotics Inc. (RR) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ: RR) securities between January 27, 2026 and 12:00 PM EST on January 29, 2026, inclusive (the “Class Period”). Richtech investors have until April 3, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RICHTECH ROBOTICS INC. (RR), CONTACT THE LAW OFFICE...
-

Natixis Syndicate UK Regulatory Announcement: Post-Stabilisation Announcement

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 6th February 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CARAC Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 28th January 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of th...
-

Rosen Law Firm Encourages GSI Technology Inc. Investors to Inquire About Securities Class Action Investigation – GSIT

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. (NASDAQ: GSIT) resulting from allegations that GSI Technology may have issued materially misleading business information to the investing public. So What: If you purchased GSI Technology securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingen...
-

OnMed Named 2026 Impact Product of the Year by Impact One Awards

NEW YORK--(BUSINESS WIRE)--OnMed Named 2026 Impact Product of the Year by Impact One Awards...
-

INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO--(BUSINESS WIRE)--Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates....
-

INVESTOR ALERT: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO--(BUSINESS WIRE)--Oracle allegedly failed to disclose that its AI strategy would result in massive increases in CapEx without equivalent near-term revenue growth....
-

GROUPE SEB : DECLARATION MENSUELLE DU NOMBRE D’ACTIONS ET DE DROITS DE VOTE – 31.01.2026

ECULLY, France--(BUSINESS WIRE)--Regulatory News: GROUPE SEB (Paris:SK): Société déclarante Dénomination sociale SEB S.A Adresse du siège social 112 Chemin du Moulin Carron, 69130 Ecully- France Marché réglementé Euronext Paris - Compartiment A ISIN FR0000121709 Nombre d’actions et de droits de vote:   31 décembre 2025 31 janvier 2026 Actions composant le capital social (1) 55 337 770 55 337 770 Droits de vote théoriques (2) 79 797 377 79 520 833 Droits de vote exerçables 79 247 411 78 970 867...